Results 181 to 190 of about 5,700,393 (345)

Notes on the Effects of Therapeutic Agents on Trypanosomes in Respect to (a) Acquired Resistance of the Parasites to the Drug, and (B) Changes in Virulence of the Strains after Escape from the Drug [PDF]

, 1908
Benjamin Moore, M. Nierenstein, John L. Todd   +2 more
openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Families' Experience of Family Therapy by Videoconference During the First Lockdown: A Qualitative Study. [PDF]

Fam Process
Barge-Chanty R, Minassian S, Hellier E, Radjack R, Grandclerc S, Moro MR.   +5 more
europepmc   +1 more source

Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.

New England Journal of Medicine, 2002
Ashkan Mohammad H. Marissa Patrick Kara Alex Laurie Ali H Afshin Forouzanfar Reitsma Sur Estep Lee Marczak M, A. Afshin, M. Forouzanfar, M. Reitsma, P. Sur, Kara Estep, Alex Lee, L. Marczak, A. Mokdad, M. Moradi-Lakeh, M. Naghavi, Joseph S. Salama, T. Vos, K. H. Abate, C. Abbafati, M. Ahmed, Z. Al-Aly, A. Alkerwi, Rajaa Al-Raddadi, Azmeraw T. Amare, A. Amegah, E. Amini, A. Amberbir, Stephen M. Amrock, R. Anjana, J. Ärnlöv, H. Asayesh, A. Banerjee, A. Barać, Estifanos Baye, D. Bennett, Masako Horino Berger, A. Beyene, S. Biadgilign, S. Biryukov, E. Bjertness, Ismael Campos-Nonato, J. Carrero, P. Cecílio, Kelly M. Cercy, Liliana G. Ciobanu, Leslie Cornaby, S. Damtew, L. Dandona, R. Dandona, S. Dharmaratne, B. Duncan, B. Eshrati, A. Esteghamati, V. Feigin, João Fernandes, Thomas Fürst, T. Gebrehiwot, Audra L Gold, P. Gona, A. Goto, T. Habtewold, K. T. Hadush, N. Hafezi-Nejad, Simon Iain Hay, M. Schmidt, F. Islami, D. Boneya, R. Kamal, A. Kasaeian, S. Katikireddi, A. Kengne, C. Kesavachandran, Y. Khader, Y. Khang, J. Khubchandani, Daniel H. Kim, Y. Kim, Y. Kinfu, S. Kosen, Tiffany Ku, B. K. Defo, G. Kumar, H. Larson, M. Leinsalu, Xiaofeng Liang, Stephen S. Lim, Patrick Liu, Alan D. Lopez, R. Lozano, A. Majeed, R. Malekzadeh, D. Malta, M. Mazidi, C. McAlinden, S. Mcgarvey, Desalegn Tadese Mengiste, Z. M. Zenebe, G. Mensah, Gert Mensink, H. Mezgebe, E. Mirrakhimov, U. Mueller, Jean Jacques N. Noubian, C. Obermeyer, F. Ogbo, M. Owolabi, G. Patton, F. Pourmalek, M. Qorbani, Anwar Rafay, R. Rai, C. Ranabhat, Nikolas Reinig, S. Safiri, J. Salomon, J. Sanabria, I. Santos, B. Sartorius, M. Sawhney, J. Schmidhuber, A. Schutte, S. Sepanlou, Moretza Shamsizadeh, S. Sheikhbahaei, Min-Jeong Shin, R. Shiri, I. Shiue, H. Shore, D. A. Santos Silva, J. Silverberg, J. Singh, S. Stranges, S. Swaminathan, R. Tabarés-Seisdedos, Fentaw Tadese, B. Tedla, B. Tegegne, A. Terkawi, J. Thakur, M. Tonelli, R. Topor-Madry, S. Tyrovolas, K. Ukwaja, O. Uthman, M. Vaezghasemi, T. Vasankari, V. Vlassov, S. Vollset, E. Weiderpass, A. Werdecker, Joshua Wesana, R. Westerman, Y. Yano, N. Yonemoto, G. Yonga, Z. Zaidi, B. Zipkin, C. Murray   +153 more
semanticscholar   +1 more source

Therapeutics

International Journal of Clinical Practice, 1957
openaire   +3 more sources

RADIUM AND ITS THERAPEUTIC EFFECTS [PDF]

, 1903
John Macintyre
openalex   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Effects of therapeutic climbing in healthcare and rehabilitation: A systematic review protocol. [PDF]

PLoS One
Delhoste B, Moudni F, Allaudeen AP, Chenuel B, Allado E.   +4 more
europepmc   +1 more source

The Therapeutic Value of Aureomycin in Dermatitis Herpetiformis**From the Department of Dermatology and Syphilology, University of Maryland.

, 1949
Harry M. Robinson, Harry M. Robinson, R. C. V. Robinson   +2 more
openalex   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source